Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Acrux Ltd
ARUXFCurrent price
0.02 USD
0 USD (0.00%)
Last closed
0.053 AUD
Company
www.acrux.com.au
ISIN
AU000000ACR3
Sector
Healthcare
Industry
Biotechnology
Exchange
AU
Capitalization
16 028 127 AUD
Yield for 12 month
+25.30 %
1Y
3Y
5Y
10Y
15Y
ARUXF
Acrux Limited, together with its subsidiaries, engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; Dapsone 5% and Dapsone 7.5% which are gels for the treatment of acne vulgaris; and Prilocaine 2.5% and Lidocaine 2.5%, a topical anaesthetic cream. It is also involved in the development of Efinaconazole, a topical solution used to treat fungal infections of toenails; Nitroglycerin 0.4%, an ointment for the treatment of pain caused by chronic anal fissure; and Acyclovir 5%, a cream for the treatment of cold sores. The company was incorporated in 1998 and is based in West Melbourne, Australia. Address: 103-113, Stanley Street, West Melbourne, VIC, Australia, 3003
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.35 AUDP/E ratio
–Dividend Yield
–Current Year
+5 103 319 AUD
Last Year
+8 449 398 AUD
Current Quarter
+683 651 AUD
Last Quarter
+4 419 670 AUD
Current Year
+1 136 744 AUD
Last Year
+1 950 709 AUD
Current Quarter
-619 495 AUD
Last Quarter
-2 281 507 AUD
Key Figures ARUXF
1 year
3 years
5 years
10 years
EBITDA
-8 356 172 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-48.18 %
PEG Ratio
–
Return On Equity TTM
-96.89 %
Wall Street Target Price
0.35 AUD
Revenue TTM
5 103 320 AUD
Book Value
0.011 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-90.3 %
Dividend Yield
–
Gross Profit TTM
4 068 822 AUD
Earnings per share
-0.02 AUD
Diluted Eps TTM
-0.02 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-113.93 %
Dividend Analytics ARUXF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ARUXF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
18.08.2015
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ARUXF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.3469
Price Sales TTM
3.1407
Enterprise Value EBITDA
-1.266
Price Book MRQ
4.9695
Financials ARUXF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ARUXF
For 52 weeks
0.035 AUD
0.088 AUD
50 Day MA
0.057 AUD
Shares Short Prior Month
–
200 Day MA
0.062 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart